Protection from septic shock subsequent to injury by dsRNAs

Details Protection from septic shock subsequent to injury by dsRNAs Protection from septic shock subsequent to injury by dsRNAs

1995-06-06

1998-06-09

Wilson, James O.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514885, 514921, A61K 3170

Patent

active

057634173

ABSTRACT:
The use of dsRNA for use in the reactivation of natural defense systems within human cells, tissues and organs reduced to inadequate function subsequent to injury. Specific treatments for various clinical phases of the biological continuous of an acquired immune deficient state are described. Protection from the toxic effects associated with increased TNF levels is described.

REFERENCES:
patent: 4795744 (1989-01-01), Carter
patent: 4945082 (1990-07-01), Carter
patent: 4963532 (1990-10-01), Carter
Surgical Forum, vol. 40, 1989, pp. 95-97 Jones et al "Restoration of delayed-type hypersensitivity . . . injury".
The Lancet, vol. 1, No. 8545, Jun. 1987 pp. 1286-1292 Carter et al "Clinical, immunological and virological . . . AIDS-related complex".
Biological Abstract #85341 (Zapata et al ) 1986. vol. 81(9).
Biological Abstract #73790 (Sharma et al) 1981. vol. 72 (11).

Affiliated with

Also associated with

Rating

Protection from septic shock subsequent to injury by dsRNAs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protection from septic shock subsequent to injury by dsRNAs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protection from septic shock subsequent to injury by dsRNAs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2199211